'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

Sandoz CEO Richard Saynor warned that U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply. The statement comes as pharmaceutical companies face potential changes to trade policies.